Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16752719 | 0.92 | L3MBTL1 (0.36) | L3MBTL1 | |
| SCHEMBL10641491 | 0.92 | L3MBTL1 (0.36) | L3MBTL1 | |
| SCHEMBL13411814 | 0.92 | L3MBTL1 (0.36) | L3MBTL1 | |
| SCHEMBL4671779 | 0.88 | — | — | |
| SCHEMBL233017 | 0.84 | ALDH1A1 (0.41) | ALDH1A1 | |
| SCHEMBL7806617 | 0.84 | — | — | |
| SCHEMBL1286520 | 0.82 | L3MBTL1 (0.30) | L3MBTL1 | |
| SCHEMBL2094922 | 0.82 | L3MBTL1 (0.30) | L3MBTL1 | |
| SCHEMBL16837384 | 0.82 | ALDH1A1 (0.44) | ALDH1A1 | |
| SCHEMBL11933712 | 0.82 | ALDH1A1 (0.44) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7528257-B1 | Process for making di-functional tetrazole diols to produce tetrazole base polymers | NAVY, UNITED STATES OF AMERICA, THE, AS REPRESENTED BY THE SECRETARY OF THE | 2009-05-05 | — | — | US | claimed |
| EP-4722199-A1 | AZOLE COMPOUND, METHOD FOR SYNTHESIZING SAID AZOLE COMPOUND, AND USE THEREOF | SHIKOKU CHEMICALS CORPORATION (JP) | 2026-04-08 | — | — | EP | disclosed |
| WO-2025047447-A1 | TETRAZOLE COMPOUND, METHOD FOR SYNTHESIZING SAID TETRAZOLE COMPOUND, AND USE THEREOF | 四国化成工業株式会社 | 2025-03-06 | — | — | WO | disclosed |
| WO-2024247919-A1 | AZOLE COMPOUND, METHOD FOR SYNTHESIZING SAID AZOLE COMPOUND, AND USE THEREOF | 四国化成工業株式会社 | 2024-12-05 | — | — | WO | disclosed |
| EP-2868649-B1 | METAL COMPLEX, AND ABSORBENT MATERIAL, STORAGE MATERIAL AND SEPARATION MATERIAL COMPRISING THE METAL COMPLEX | KURARAY CO (JP) | 2021-04-07 | — | — | EP | disclosed |
| US-9586170-B2 | Metal complex, and adsorbent material, storage material and separation material comprising metal complex | KURARAY CO., LTD. (JP) | 2017-03-07 | — | — | US | disclosed |
| EP-2960227-A1 | METHOD FOR PRODUCING METAL COMPLEX | Kuraray Co., Ltd. (JP) | 2015-12-30 | — | — | EP | disclosed |
| US-20150361102-A1 | METHOD FOR PRODUCING METAL COMPLEX | KURARAY CO., LTD. (JP) | 2015-12-17 | — | — | US | disclosed |
| US-20150165415-A1 | METAL COMPLEX, AND ABSORBENT, OCCLUSION MATERIAL AND SEPARATION MATERIAL PRODUCED THEREFROM | KURARAY CO., LTD. (JP) | 2015-06-18 | — | — | US | disclosed |
| US-20150144085-A1 | METAL COMPLEX, AND ABSORBENT MATERIAL, STORAGE MATERIAL AND SEPARATION MATERIAL COMPRISING METAL COMPLEX | KURARAY CO., LTD. (JP) | 2015-05-28 | — | — | US | disclosed |
| EP-2871174-A1 | METAL COMPLEX, AND ABSORBENT, OCCLUSION MATERIAL AND SEPARATION MATERIAL PRODUCED THEREFROM | Kuraray Co., Ltd. (JP) | 2015-05-13 | — | — | EP | disclosed |
| EP-2868649-A1 | METAL COMPLEX, AND ABSORBENT, OCCLUSION MATERIAL AND SEPARATION MATERIAL PRODUCED THEREFROM | Kuraray Co., Ltd. (JP) | 2015-05-06 | — | — | EP | disclosed |
| US-20140107135-A1 | PYRIMIDINONE INHIBITORS OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 | AUSPEX PHARMACEUTICALS, INC. (US) | 2014-04-17 | — | — | US | disclosed |
| US-7601747-B1 | One-pot process for making di-functional di-tetrazole diols to produce tetrazole based polymers | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2009-10-13 | — | — | US | disclosed |
| US-7528257-B1 | Process for making di-functional tetrazole diols to produce tetrazole base polymers | NAVY, UNITED STATES OF AMERICA, THE, AS REPRESENTED BY THE SECRETARY OF THE | 2009-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140107135-A1 | PYRIMIDINONE INHIBITORS OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 | PLA2G1B, PLA2G4A, PLA2G4B | ALDH1A1 1423/4885LMNA 622/4885L3MBTL1 3877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.